AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States.
Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support.
The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services.
It serves adult and senior cancer patients.
The company operates 67 clinic locations.
The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Country | United States |
IPO Date | Jun 4, 2020 |
Industry | Medical - Care Facilities |
Sector | Healthcare |
Employees | 800 |
CEO | Dr. Daniel Virnich FACHE, M.B.A., M.D. |
Contact Details
Address: 18000 Studebaker Road Cerritos, California United States | |
Website | https://theoncologyinstitute.com |
Stock Details
Ticker Symbol | TOI |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001799191 |
CUSIP Number | 68236X100 |
ISIN Number | US68236X1000 |
Employer ID | 00-0000000 |
SIC Code | 8011 |
Key Executives
Name | Position |
---|---|
Dr. Daniel Virnich FACHE, M.B.A., M.D. | Chief Executive Officer & Executive Director |
Laura Szitar | Chief People Officer |
Rob Carter | Chief Financial Officer |
Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H. | Chief Medical Officer |
Jeremy N. Castle M.B.A. | Chief Operations Officer |
Jordan McInerney | Chief Development Officer |
Mark Hueppelsheuser Esq. | General Counsel |
Richard Alan Barasch | Chairman of the Board |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 07, 2025 | 4 | Filing |
Dec 19, 2024 | 8-K | Current Report |
Dec 06, 2024 | SCHEDULE 13G/A | [Amend] Filing |
Dec 05, 2024 | 4 | Filing |
Dec 02, 2024 | 4 | Filing |
Nov 25, 2024 | 4 | Filing |
Nov 25, 2024 | 4 | Filing |
Nov 25, 2024 | 4 | Filing |
Nov 25, 2024 | 4 | Filing |
Nov 25, 2024 | 4 | Filing |